NFATC4 and cardiac hypertrophy: Early systolic and diastolic decompensation (after 1 month) and cardiac hypertrophy (after 3 months), as indicated by an increase in LV posterior wall thickness (PWth), LV end-diastolic pressure (LVEDP), dP/dtmin, ejection fraction % (EF%) and NFATc4 activity.